Home Journals Articles Updates About
CN
image
收藏切换
A highly sensitive fluorescent HClO probe for discrimination between cancerous and normal cells/tissues
收藏切换
PDF
Linfang Wanga, Jing Liub, *, Minghao Rena, Wei Guob, *
Chinese Chemical Letters | 2024, 35(6) : 108945
Less
收藏切换
Chinese Chemical Letters | 2024, 35(6): 108945
• Communication •
A highly sensitive fluorescent HClO probe for discrimination between cancerous and normal cells/tissues
Full
Linfang Wanga, Jing Liub, *, Minghao Rena, Wei Guob, *
Affiliations
  • a Department of Chemistry, Changzhi University, Changzhi 046011, China
  • b School of Chemistry and Chemical Engineering, Shanxi University, Taiyuan 030006, China
Published: 2024-06-15 doi: 10.1016/j.cclet.2023.108945
Outline
收藏切换

Elevated level of hypochlorous acid (HClO) is closely associated with cancer development. Identifying HClO level in cancer cells would provide important evidence in either early-stage cancer diagnostics or monitoring of its treatment efficiency. In this work, a new pyronine-based fluorescent probe for rapid and sensitive detection of HClO was developed by condensing meso–formyl pyronine (PyCHO) with 2-hydrazinopyridine to form meso–pyridylhydrazone-functionalized pyronine PyHP, PyHP is nonfluorescent due to the excited-state C=N isomerization nonradiative decay, whereas the HClO-triggered formation of meso–triazolopyridyl pyronine PyTP abolishes the C=N isomerization and thus greatly enhances the fluorescence. With the probe, the cancer cells/tumor were distinguished with high-contrast from normal ones by laser confocal fluorescence imaging, and the tumor-to-normal (T/N) ratios obtained exceed the clinically acceptable threshold of 2.0. Moreover, its capability of in vivo imaging tumor was also demonstrated. These results indicate the potential of PyHP as an effective tool in the early clinical diagnosis of cancers.

Meso-pyridylhydrazone-functionalized pyronine  /  Meso-substituents  /  Tumor-to-normal (T/N) ratios  /  Fluorescent probes  /  Hypochlorous acid
Linfang Wang, Jing Liu, Minghao Ren, Wei Guo. A highly sensitive fluorescent HClO probe for discrimination between cancerous and normal cells/tissues[J]. Chinese Chemical Letters, 2024 , 35 (6) : 108945 - . DOI: 10.1016/j.cclet.2023.108945
Full Text
Less
Cancer has been a severe threat to human health, and millions die of cancer yearly [1,2]. According to the evaluation of the World Health Organization, by 2035, there will be 24 million new cancer cases and 14.5 million cancer-related deaths, out of which approximately 30% could hold the chance if the cancers could be diagnosed earlier [3]. However, owing to the lack of specificity and sensitivity of current techniques, accurate diagnosis can be achieved only in the middle or late stage of the tumor [4]. Most patients with cancer, including breast, stomach, ovarian, colonic, and so forth, are already at the late stages of disease when diagnosed [5,6]. As a result, patients often miss the optimal treatment window, which also is one of the leading causes of high death rates. In addition, studies demonstrated that the five-year survival rate for many early-stage cancers is above 50%, and it falls to below 20% when cancer cells are metastasized to distant tissue [3,7–9]. Overall, it is highly urgent for early detection and diagnosis of cancers, the key of which lies in the discrimination of cancer cells/tissues from normal cells/tissues using efficient tools [7,10–13].
Small molecule-based fluorescent techniques, featured with the advantages of visualization, sensitivity, easy modification, and low biological damage [14–18], have shown great potential as noninvasive diagnostics tools for diagnosing cancers. The most commonly used strategy for designing tumor-targeted fluorescent probes has been the use of chemical conjugation of fluorophores with recognition units that can specifically bind to or react with the overexpressed cancer biomarkers. Among those biomarkers, reactive oxygen species (ROS), such as hypochlorous acid (HClO) [19–23], is gaining increasing attention, given that cancer cells commonly have the elevated ROS level due to the dysregulated metabolism, i.e., aerobic glycolysis (Warburg effect) [24,25]. Taking advantage of this exclusive feature, in recent years, many efforts have been devoted to discriminating cancer cells from normal ones by exploiting fluorescent ROS probes [7,26–31]. However, the efficacy of these probes has been challenged. One possible reason is that the HClO level between cancer cells and normal cells, although being higher in the former, is still of little difference, making it difficult to reach the clinical requirement (tumor-to-normal (T/N) cell/tissue ratios being more than 2-fold). To solve this problem, there are two ways for choice: one is to increase the ROS level in cancer cells, but not in normal cells, through drug stimulation [11]; the other is to enhance the sensitivity of fluorescent ROS probes so that the probes can sensitively respond to the minor differences in ROS levels to realize the distinction between cancer cells and normal cells. But in any case, designing highly sensitive and selective fluorescent ROS probes is highly desired at present.
Meso-substituted pyronine, boron dipyrromethene (BODIPY), and cyanine have been researched and highlighted in recent literatures [32–37], because the photophysical properties of these dyes, such as fluorescence off-on switching, Stokes shift, and absorption and emission wavelengths, can be adjusted by analyte-triggered changing of meso–substituents [33,34]. On this basis, we recently introduced an aldehyde functional group at the 9th position of pyronine fluorophore to achieve meso–formyl pyronine (PyCHO) in a hope that it can serve as a molecular platform to construct fluorescent probes [38]. In this work, a new pyronine-based fluorescent probe was developed by condensing PyCHO with 2-hydrazinopyridine to form meso–pyridylhydrazone-functionalized pyronine PyHP (Scheme 1A). PyHP displayed a great fluorescence off-on response (200-fold) toward HClO based on the HClO-triggered formation of meso–triazolopyridyl pyronine PyTP (Scheme 1B) that abolishes the C=N isomerization-induced fluorescence quenching. The detection limit of the probe for HClO was determined to be 0.9 nmol/L based on 3σ/k, indicative of its high sensitivity. This probe has successfully been utilized to distinguish cancer from normal cells/tissues in vitro and in vivo in terms of their difference in intracellular basal ROS levels.
With probe PyHP in hand, we first evaluated its photophysical properties and its ability to sense HClO in phosphate buffered saline (PBS, 10 mmol/L, pH 7.4, containing 0.1% CH3CN). As shown in Fig. 1, PyHP presented two broad absorption peaks at 500 and 595 nm, respectively, and exhibited almost no fluorescence (Φf = 0.007) upon excitation at 580 nm due to the rotation of the C=N bond [39]. After adding HClO to the PyHP solution, a prominent absorption peak centered at 600 nm was observed, accompanied by a strong fluorescence emission at 628 nm (Φf = 0.135). The fluorescence enhancement reaches up to 200-fold, indicating that the reaction of PyHP and HClO generates highly fluorescent PyTP [40,41]. The generation of PyTP was further confirmed by 1H-nuclear magnetic resonance (NMR), 13C NMR, and high performance liquid chromatography-high resolution mass spectroscopy (HPLC—HRMS) analysis (Figs. S9–S11 in Supporting information), where the main product produced by the reaction of PyHP and HClO could be classified as PyTP (m/z = 440.2444, calculated value 440.2445, Fig. S11). It is worth noting that the reaction of PyHP and HClO could be completed in less than 15 s, indicative of the rapid sensing ability of the probe for HClO (Fig. S1 in Supporting information).
Subsequently, we performed the fluorescence titration assay. As shown in Fig. 2A, after adding 0−5 equiv. HClO to the PyHP solution, the fluorescence intensity at 628 nm gradually increased and reached saturation at about 2 equiv. And the fluorescence intensity of PyHP at 628 nm has an excellent linear relationship (R2 = 0.9947) with the HClO concentrations in the range of 0−1.4 equiv. (Fig. 2B). Thereby, the detection limit was determined to be as low as 0.9 nmol/L (3σ/k), indicating the possibility of the probe to sense a basal level of HClO within cancer cells. Furthermore, to evaluate the selectivity, we tested the fluorescence response of PyHP towards various biologically relevant species, including various cations, anions, reducing substances, and oxidizing substances. As expected, except for HClO, other biologically relevant species only trigger minor or negligible fluorescence enhancement at 628 nm (Figs. 2C and D, Fig. S2 in Supporting information), indicative of the excellent selectivity of PyHP toward HClO. In addition, the responses of PyHP to HClO at different pH environments were also studied, aiming to explore whether PyHP is also applicable in various physiological environment. In fact, in the pH range of 4−8, PyHP displayed obvious fluorescence off−on response towards HClO (Fig. S3 in Supporting information), indicating that the probe can be used to image HClO under physiological pH. Taken together, the above results establish that PyHP has superior sensitivity and selectivity for HClO, thus being promising to be used to distinguish cancer from normal cells.
To figure out whether the high selectivity of PyHP for HClO observed in PBS is also feasible in the complex cell environment, we performed the cell imaging assays. As shown in Fig. 3, when normal COS-7 cells were pretreated with PyHP (1 µmol/L) and then treated respectively with various ROS, including HClO, ONOOˉ, NO, H2O2, 1O2, •OH, and O2•− only the HClO-treated cells produced strong fluorescence, which is about 4 times stronger than that observed in other groups. These results strongly indicate that PyHP could selectively image HClO in the complex cell environment. And note that, the costaining assays revealed that PyHP accumulated preferentially in lysosomes (Fig. S4 in Supporting information).
Further, we want to know whether PyHP could also be used to image intracellular endogenous HClO. Thus, the ability of the PyHP to image exogenous HClO was investigated. A series of images was captured in RAW264.7 cells incubated with PyHP under different conditions. As shown in Fig. 4, when RAW264.7 cells were treated with PyHP, only very weak fluorescence was observed; when the cells were pretreated with PyHP and then incubated with HClO, a noticeable fluorescence enhancement was observed; when the cells were treated with lipopolysaccharides (LPS) [42] to induce inflammation, and then incubated with PyHP, bright intracellular fluorescence was also observed, indicating that the probe could also image endogenous HClO. It is known that endogenous HClO is generated from hydrogen peroxide and chloride under the catalysis of myeloperoxidase. As expected, when RAW264.7 cells were pretreated with LPS and 4-aminobenzoic acid hydrazide (ABAH, a myeloperoxidase inhibitor) [43] and then incubated with PyHP, the intracellular fluorescence was effectively inhibited due to the blockage of the HClO production pathway. Taken together, these results revealed that PyHP could also be used to image intracellular endogenous HClO.
Encouraged by the above excellent results, we subsequently assessed the potential of PyHP to distinguish cancer cells from normal ones based on the elevated level of endogenous HClO in cancer cells relative to that in normal cells. A variety of normal cells (BEAS-2B, HUCEC, COS-7) and cancer cells (A549, HepG2, T98G) were selected for the assays. As shown in Fig. 5, when normal cells were incubated with PyHP for 10 min, only a weak fluorescence signal was detected, consistent with the low level of HClO in normal ones; when cancer cells were treated with PyHP under the same condition, they displayed remarkable fluorescence, approximately 4-fold stronger than that in normal cells and exceeding the clinically acceptable threshold of 2.0. The results reveal that PyHP can be utilized to distinguish cancer cells from normal cells.
Further, we investigated the potential of PyHP to image endogenous HClO in living nude mice using a Bruker In vivo FX Pro-small animal optical imaging system with an excitation filter at 590 nm and an emission filter at 700 nm. As shown in Fig. S5 (Supporting information), when the mouse was intraperitoneally (i.p.) injected with PyHP, almost no fluorescence signal was observed; when the mouse was i.p. injected with LPS (2 mg/mL, 100 µL) for 4 h to induce inflammation, followed by i.p. injection of PyHP, an obvious fluorescence signal was observed in the abdominal region, indicating that PyHP could image endogenous HClO in the inflamed mouse model. All the animal experiments were carried out in accordance with the relevant laws and guidelines issued by the Ethical Committee of Shanxi University and the studies were approved by Ethical Committee of Shanxi University.
Encouraged by the above results, we finally appraised the capacity of PyHP in lighting up tumor from mouse models. As shown in Fig. 6, when PyHP (1 mmol/L) was injected into mouse through tail vein, apparent fluorescence was observed at the tumor site after 20 h (Fig. 6A), indicating that PyHP could light up tumor. Then, by dissecting the tumor-bearing mice and imaging heart, liver, spleen, lung, kidney, and tumor, it was found that these organs, except for tumor, only displayed negligible fluorescence; in sharp contrast, tumor presented bright fluorescence (Fig. 6B). The results suggested that PyHP could selectively image tumors due to the overexpressed HClO. Therefore, PyHP is promising to serve as a detection tool to assist in tumor resection in a clinical setting.
In summary, by condensing PyCHO with 2-hydrazinopyridine, a meso–pyridylhydrazone-functionalized pyronine PyHP as a fluorescent probe for HClO was facilely achieved. The probe could highly selectively sense HClO based on the HClO-triggered generation of meso–triazolopyridyl pyronine PyTP that abolishes the C=N isomerization-induced fluorescence quenching and greatly enhances the fluorescence. The excellent sensing performance of the probe for HClO is reflected by large fluorescence off−on response (> 200-fold), short response time (< 15 s), high selectivity, and low detection limit (0.9 nmol/L). Based on the elevated level of HClO in cancer cells or tumors, the probe has been successfully utilized to distinguish cancer cells/tumors from normal ones with high T/N ratios of more than 4. The future research work would concentrate on red-shifting the excitation/emission wavelengths of this type of probe by employing silicon-pyronine or phospha-pyronine for long-term and deep imaging of HClO.
Declaration of competing interest
Less
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgments
Less
We acknowledge Scientific and Technological Innovation Program of Colleges and Universities in Shanxi Province (Nos. 2021L529, 2021L530) and the Fund for Shanxi "1331 Project".
Supplementary materials
Less
Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.cclet.2023.108945.
References
Less
[1]
W. Wang, J. Xiong, X. Song, et al., Anal. Chem. 92 (2020) 13305–13312.
[2]
H. Zhang, J. Fan, J. Wang, et al., J. Am. Chem. Soc. 135 (2013) 11663–11669.
[3]
L. Fass, Mol. Oncol. 2 (2008) 115–152.
[4]
H. Zhang, J. Liu, B. Hu, et al., Chem. Sci. 9 (2018) 3209–3214.
[5]
T. Huang, W. Kang, B. Zhang, et al., Mol. Cancer 15 (2016) 9.
[6]
M. Mao, X. Wei, H. Sheng, et al., Oncol. Lett. 14 (2017) 7417–7424.
[7]
K. Wang, C. Liu, H. Zhu, et al., Coordin. Chem. Rev. 477 (2023) 214946.
[8]
J. Li, X. Guan, Z. Fan, et al., Cancers 12 (2020) 2767.
[9]
D. Crosby, S. Bhatia, K.M. Brindle, Science 375 (2022) eaay9040.
[10]
H. Zhang, J. Liu, L. Wang, et al., Biomaterials 158 (2018) 10–22.
[11]
J. Liu, M. Liu, H. Zhang, W. Guo, Angew. Chem. Int. Ed. 60 (2021) 12992–12998.
[12]
J. Yan, X. Liang, Q. Zhang, L. Wang, W. Lin, Chin. Chem. Lett. 35 (2024) 108408.
[13]
Y. Sun, X. Zhou, L. Sun, et al., Chin. Chem. Lett. 33 (2022) 4229–4232.
[14]
W. Chen, Q. Fang, D. Yang, et al., Anal. Chem. 87 (2015) 609–616.
[15]
L. Yuan, F. Jin, Z. Zeng, et al., Chem. Sci. 6 (2015) 2360–2365.
[16]
W. Zhang, F. Huo, F. Cheng, C. Yin, J. Am. Chem. Soc. 142 (2020) 6324–6331.
[17]
J. Han, S. Yang, B. Wang, X. Song, Anal. Chem. 93 (2021) 5194–5200.
[18]
L. Jiang, T. Chen, E. Song, et al., Chem. Eng. J. 427 (2022) 131563.
[19]
Q. Zhou, S. Wang, X. Ran, et al., Chin. Chem. Lett. 34 (2023) 107922.
[20]
M. Chen, S. Lin, X. Chen, et al., Sens. Actuator. B: Chem. 386 (2023) 133749.
[21]
C. Duan, M. Won, P. Verwilst, et al., Anal. Chem. 91 (2019) 4172–4178.
[22]
S. Wang, B. Zhu, B. Wang, et al., Chin. Chem. Lett. 32 (2021) 1795–1798.
[23]
D. Sun, Z. Chen, J. Hu, et al., Chin. Chem. Lett. 33 (2022) 4478–4494.
[24]
R.M. Pascale, D.F. Calvisi, M.M. Simile, C.F. Feo, F. Feo, Cancers 12 (2020) 2819.
[25]
M.G. Vander Heiden, L.C. Cantley, C.B. Thompson, Science 324 (2009) 1029–1033.
[26]
H. Zhu, J. Fan, J. Wang, H. Mu, X. Peng, J. Am. Chem. Soc. 136 (2014) 12820–12823.
[27]
Z. Liang, Y. Sun, H. Zeng, et al., Anal. Chem. 92 (2020) 16130–16137.
[28]
Y. Xiao, X. Yin, P. Sun, et al., Chin. Chem. Lett. 33 (2022) 5051–5055.
[29]
Y. Chen, J.Y. Lim, X.H. Wu, et al., Dyes Pigm. 195 (2021) 109666.
[30]
X. Wei, H. Zhang, Y. Sun, J. Liu, Z. Li, Analyst 146 (2021) 495–501.
[31]
Z. Wu, Z. Liang, S. Guo, et al., Sens. Actuator. B: Chem. 359 (2022) 131577.
[32]
C. Wang, W. Chi, Q. Qiao, et al., Chem. Soc. Rev. 50 (2021) 12656–12678.
[33]
M. Yan, D. He, L. Zhang, et al., TrAC Trends Analyt. Chem. 157 (2022) 116771.
[34]
D. He, L. Zhang, Y. Sun, Coordin. Chem. Rev. 461 (2022) 214507.
[35]
Y. Song, H. Zhang, X. Wang, et al., Anal. Chem. 93 (2021) 1786–1791.
[36]
W. Chi, Q. Qiao, R. Lee, et al., Angew. Chem. Int. Ed. 58 (2019) 7073–7077.
[37]
K.M. Atkinson, J.J. Morsby, S.S.R. Kommidi, B.D. Smith, Org. Biomol. Chem. 19 (2021) 4100–4106.
[38]
L. Wang, J. Liu, H. Zhang, W. Guo, Sens. Actuator. B: Chem. 334 (2021) 129602.
[39]
J.S. Wu, W.M. Liu, X.Q. Zhuang, et al., Org. Lett. 9 (2007) 33–36.
[40]
H. Teng, J. Tian, D. Sun, et al., Sens. Actuators B: Chem. 319 (2020) 128288.
[41]
Y. Zhang, H. Teng, Y. Gao, et al., Chin. Chem. Lett. 31 (2020) 2917–2920.
[42]
R.B. Lorsbach, W.J. Murphy, C.J. Lowenstein, S.H. Snyder, S.W. Russell, J. Biol. Chem. 268 (1993) 1908–1913.
[43]
J.J. Hu, N.K. Wong, Q. Gu, et al., Org. Lett. 16 (2014) 3544–3547.
Appendix
Less
Year 2024 volume 35 Issue 6
PDF
39
21
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.cclet.2023.108945
  • Receive Date：2023-07-18
  • Online Date：2025-11-21
  • Published：2024-06-15
Article Data
Affiliations
History
  • Received：2023-07-18
  • Revised：2023-08-16
  • Accepted：2023-08-17
Affiliations
    a Department of Chemistry, Changzhi University, Changzhi 046011, China
    b School of Chemistry and Chemical Engineering, Shanxi University, Taiyuan 030006, China
References
Share
https://castjournals.cast.org.cn/joweb/ccl/EN/10.1016/j.cclet.2023.108945
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House